News

Case studies highlighting vMap’s effectiveness at localizing arrhythmia termination sites in complex cases to be presented alongside vMap time study

The six-month EXCITE-HCM study of 70 patients will study the effects of exercise on electrical activity and blood flow using Vivalink's medical wearable ECG sensor and cloud data services.

-The Librexia program is the most comprehensive Factor XIa Phase 3 clinical development program, and will provide indispensable data from nearly 50,000 patients across three simultaneous trials including Librexia STROKE, Librexia...

REDWOOD CITY, Calif., March 1, 2023--Galvanize Therapeutics, Inc. today announced the first human investigational use of its large-area, focal, Pulsed Electric Field (PEF) ablation catheter called QuickShot™ in the QuickShot PEF-AF...

February 24, 2023 10:41 AM Eastern Standard Time--MANHASSET, N.Y.--Starting in the brain and extending to our organs, the vagus nerve helps communicate and maintain how the body functions, including heart rate, breathing and immune response....

Partners of advanced medical device reprocessor significantly reduced their carbon emissions and saved an average of more than $500,000 on devices in 2022. SCOTTSDALE, Ariz., Feb. 23, 2023 /-- Innovative Health,...

EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature

Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by...

Asundexian is an oral inhibitor of Factor XIa that Bayer is developing as a potential treatment for prevention of stroke in atrial fibrillation, as well as for secondary prevention in patients with a non-cardioembolic ischemic stroke...

Cardiovascular diseases affects over 3 million Canadians, and over 750, 000 Canadians are living with heart failure. Almost 1 in 3 Canadians are touched by heart failure, and over 100,000 new Canadians are diagnosed with heart failure every...